drugset / Trial / NCT05151146
A Phase 1 Study of ANJ900 Chinese Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This will be a Phase 1, randomised, open label, 3 way crossover study in healthy male and female Chinese subjects. Subjects will participate in 3 treatment periods and will be randomised in a 1:1:1 ratio to 1 of 3 treatment sequences. There will be a washout period of 7 days between doses.
Timeline
- Start
- 2021-10-15
- Primary completion
- 2021-12-30
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 1000 mg | — |
| Subject | Metformin | Small molecule | 1800 mg | — |
Indications
No indication recorded.